BioNTech SE (BNTX) Latest Stock News & Headlines - Yahoo …
WEBGet the latest BioNTech SE (BNTX) stock news and headlines to help you in your trading and investing decisions.
BioNTech Announces Positive Topline Phase 2 Results for mRNA ...
WEBMAINZ, Germany, July 30, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced positive topline data from the ongoing Phase 2 clinical trial (EudraCT No.: 2020-002195-12; NCT04526899) in patients with unresectable stage III or IV melanoma whose disease had progressed following anti-PD- (L)1-containing t...
Buy Rating Affirmed for BioNTech SE Following Promising Clinical …
WEB4 days ago · Burns covers the Healthcare sector, focusing on stocks such as BioNTech SE, Immix Biopharma, Inc., and Tango Therapeutics. According to TipRanks , Burns has an average return of -16.6% and a 30.89 ...
BioNTech SE: A Strong Buy on BNT327’s Promising Cancer …
WEB3 days ago · BioNTech SE is a Germany-based biotechnology company that develops and manufactures immunotherapies for cancer, infectious diseases, allergies and autoimmune disorders. Read More on BNTX:
Jefferies upgrades BioNTech SE (BNTX) to a Buy - Markets Insider
WEB2 days ago · Jefferies analyst Akash Tewari upgraded BioNTech SE (BNTX – Research Report) to a Buy today and set a price target of $150.00. The company’s shares closed yesterday at $123.47. The company’s ...
BioNTech SE (BNTX) Stock Price, News, Quote & History - Yahoo …
WEBFind the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
BioNTech
WEBLooking for our latest news, events or SEC filings? Sign-up for our alerts here.
Press Releases - BioNTech
WEBAug 16, 2024 · BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update. Read on. 30 July 2024. BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma. Read on. 22 July 2024. BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024.
BioNTech SE - The New York Times
WEBNews about BioNTech SE. Commentary and archival information about BioNTech SE from The New York Times.
BNTX.O - | Stock Price & Latest News | Reuters
WEBSep 11, 2024 · Get Biontech SE (BNTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
- Some results have been removed